Brookfield Corp’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-49,169
Closed -$6.67M 652
2022
Q2
$6.67M Buy
49,169
+11,732
+31% +$1.77M 0.03% 205
2022
Q1
$6.24M Buy
37,437
+5,777
+18% +$1.1M 0.02% 225
2021
Q4
$5.66M Sell
31,660
-11,517
-27% -$2.06M 0.02% 200
2021
Q3
$7.64M Sell
43,177
-2,905
-6% -$481K 0.03% 168
2021
Q2
$7.41M Buy
46,082
+12,324
+37% +$1.9M 0.03% 165
2021
Q1
$5.05M Sell
33,758
-28,111
-45% -$3.41M 0.02% 161
2020
Q4
$6.11M Buy
+61,869
New +$6.18M 0.03% 128

Other funds holding CNXC

Brookfield Corp's CNXC Position: Q3 2022 in Review

Brookfield Corp sold out of Concentrix (CNXC) in Q3 2022, closing a stake of 49,169 shares — an estimated $6.67M sold.

Brookfield Corp first reported a position in CNXC in Q4 2020 and held it in 7 quarters. The position peaked at $7.64M in Q3 2021. 311 funds tracked by Wall St. Rank hold CNXC as of Q3 2022.

  • Brookfield Corp reported no remaining Concentrix position as of Q3 2022 after selling out during the quarter.
  • Brookfield Corp sold 49,169 Concentrix shares in Q3 2022, an estimated $6.67M.
  • Brookfield Corp first reported a position in Concentrix in Q4 2020 and held it in 7 quarters.
  • Brookfield Corp's Concentrix position peaked at $7.64M in Q3 2021.
  • 311 funds tracked by Wall St. Rank held Concentrix as of Q3 2022.

Based on Brookfield Corp's 13F filing for Q3 2022, filed 14 Nov 2022.